Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. 詳細を表示
CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.34 | 3.22891566265 | 41.5 | 43.34 | 36.01 | 87641 | 39.66316543 | CS |
4 | 3.5392 | 9.00541464805 | 39.3008 | 52 | 36.01 | 120304 | 44.43691773 | CS |
12 | 5.9 | 15.9718462371 | 36.94 | 98 | 36.01 | 147936 | 59.25078991 | CS |
26 | 9.73 | 29.3868921776 | 33.11 | 98 | 30.74 | 101229 | 53.0210831 | CS |
52 | -5.38 | -11.1571961842 | 48.22 | 98 | 30.005 | 74485 | 51.88029572 | CS |
156 | 29.84 | 229.538461538 | 13 | 98 | 13 | 74838 | 51.01551082 | CS |
260 | 29.84 | 229.538461538 | 13 | 98 | 13 | 74838 | 51.01551082 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約